In Vivo Screening Data Summary

NCI In Vivo Screening Data

Human Mammary Carcinoma MX-1 Xenograft (subcutaneous) in NU/NU Swiss (nude) mice

NSC 119875
CAS 15663-27-1
Cisplatin; Plantinol AQ; Cis-DDP

Chemical Data
Schedule (route) Endpoint Vehicle Dose Treated/Control (%) Observations
Q04DX003 (ip) optimum tumor weight change saline 2.0 mg/kg/injection 74.0 Antitumor endpoint evaluated on day 33; 05/05 animals surviving on day 35
Q04DX003 (ip) optimum tumor weight change saline 4.0 mg/kg/injection 30.0 Antitumor endpoint evaluated on day 33; 05/05 animals surviving on day 35
Q04DX003 (ip) optimum tumor weight change saline 8.0 mg/kg/injection -69.0 Antitumor endpoint evaluated on day 33; 04/05 animals surviving on day 35